Abstract
Over the last 15 years whole organ pancreas transplantation has emerged as the treatment of choice for selected patients with uremia and Type I Diabetes Mellitus. Improvements in surgical technique, better understanding of transplant related complications and advances in immunosuppressive therapy have encouraged the application of this procedure to an increasing number of patients. Pancreas transplantation occurs under three primary scenarios: simultaneous kidney pancreas transplantation, pancreas transplantation after kidney transplantation, and pancreas transplant alone. Overall results are excellent with 90%-95% one-year patient survival, and 85%-90% of patients achieving normal glycemic control. There also exists a significant long-term survival advantage among the simultaneous kidney pancreas transplant group.
Original language | English (US) |
---|---|
Pages (from-to) | 269-272 |
Number of pages | 4 |
Journal | South Dakota journal of medicine |
Volume | 57 |
Issue number | 7 |
State | Published - Jul 2004 |
ASJC Scopus subject areas
- Medicine(all)